Face transplantation: Part II-an ethical perspective

Area of Science:

• Medical Ethics
• Surgical Innovation
• Transplantation Medicine

Background:

• A proposal for the first face transplant was submitted to the University of Louisville's Institutional Review Board (IRB) in May 2004.
• Previous reports from England (2003) and France (2004) advised against face transplantation due to risks outweighing benefits.
• Established microsurgical skills do not negate the complex ethical and medical considerations of face transplantation.

Purpose of the Study:

• To evaluate the ethical and medical viability of performing the first face transplant.
• To analyze the potential risks and benefits associated with face transplantation.
• To determine if current medical knowledge and ethical standards justify proceeding with face transplantation.

Main Methods:

• Review of existing ethical guidelines and surgical literature.
• Analysis of potential psychological impacts on recipients and donor families.
• Assessment of long-term risks, including immunosuppression and immune rejection.

Main Results:

• Face transplantation involves more than technical skill, encompassing significant psychological and long-term health risks.
• The current risks of face transplantation, including potential immune rejection and the need for lifelong immunosuppression, are substantial.
• Ethical considerations suggest that further time is required to refine the procedure and mitigate life-threatening dangers.

Conclusions:

• Face transplantation is not yet medically or ethically justifiable due to unknown dangers and high risks.
• More research is essential to lower rejection rates and improve long-term patient outcomes.
• Proceeding with face transplantation at this time would be medically irresponsible and ethically objectionable.